Tomoya Sameshima

6PUBLICATIONS
13CO-AUTHORS
Molecular targetsProteins and peptidesCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug.

|Sep 25, 2019
Identification of 2,6-Disubstituted 3<i>H</i>-Imidazo[4,5-<i>b</i>]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells.

Hiroyuki Takada, Akira Kaieda, Michiko Tawada

|Aug 29, 2019
Small-Scale Panel Comprising Diverse Gene Family Targets To Evaluate Compound Promiscuity.

Tomoya Sameshima, Tomoya Yukawa, Yoshihiko Hirozane

|Aug 02, 2018
Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.

Masahiro Ito, Toshio Tanaka, Akinori Toita

|Jan 03, 2018
Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.

Tomoya Sameshima, Takeshi Yamamoto, Osamu Sano

|May 19, 2017
Universal and Quantitative Method To Evaluate Inhibitor Potency for Cysteinome Proteins Using a Nonspecific Activity-Based Protein Profiling Probe.

Tomoya Sameshima, Yukiya Tanaka, Ikuo Miyahisa

Pageof 1

Frequent Collaborators

2 joint publications

Masahiro Ito

2 joint publications

Hironori Kokubo

1 joint publications

Satoshi Sogabe

1 joint publications

Gregg B Morin